Preventive strategies to reduce the rate of periprosthetic infections in total joint arthroplasty; a comprehensive review

• Published in: Archives of orthopaedic and trauma surgery
• Main Authors: Egerci, Omer Faruk, Yapar, Aliekber, Dogruoz, Fırat, Selcuk, Huseyin, Kose, Ozkan
• Format: Journal Article
• Language: English
• Published: Germany 18-04-2024
• Subjects: Prevention; Periprosthetic joint infections; Total knee arthroplasty; Total hip arthroplasty
• ISSN: 1434-3916; 1434-3916
• DOI: 10.1007/s00402-024-05301-w

The increasing frequency of total hip (THA) and knee arthroplasties (TKA) is marred by the rise in periprosthetic joint infections (PJIs) and surgical site infections (SSIs), with PJIs incurring costs over $1.62 billion as of 2020 and individual case management averaging $90,000. SSIs additionally burden the U.S. healthcare economy with billions in expenses annually. PJI prevalence in primary THA and TKA ranges from 0.5% to 2.4%, spiking to 20% in revisions and representing 25% of TKA revision causes. Projections estimate up to 270,000 annual PJI cases by 2030. Often caused by gram-positive bacteria, particularly methicillin-resistant staphylococci, these infections demand preventive measures. This review dissects PJI prevention across preoperative, intraoperative, and perioperative phases, aligning with evidence-based CDC and WHO guidelines. Preoperative measures include managing diabetes, obesity, tobacco use, Staphylococcus aureus screening and nasal decolonization, nutritional optimization, and management of inflammatory arthropathies. Intraoperatively, antibiotic prophylaxis, skin preparation, operative room environmental controls, surgical technique precision, and irrigation options are scrutinized. Perioperative concerns focus on anticoagulation, blood management, and infection risk mitigation. Integrating these strategies promotes a patient-centric care model, aiming to reduce PJI incidence, improve patient outcomes, and increase care cost-effectiveness in joint arthroplasty.